Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alexanian

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
Southern Medical Journal|December 1, 1984
Connective tissue disease manifested as multiple myelomaC J Tula, L Berman, R Alexanian
Journal of the Neurological Sciences|August 23, 2024
Dopaminergic progenitors generated by small molecule approach survived, integrated, and promoted functional recovery in (6-OHDA) mouse model of Parkinson's diseaseArshak R Alexanian, Andrey Sorokin, Megan Duersteler
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 1, 1997
[Multiple myeloma and chronic lymphocytic leukemia]J Labardini-Méndez, R Alexanian, B Barlogie
The New England Journal of Medicine|October 19, 1995
Clinical problem-solving: costly errorsD M Weber, D Daliani, R Alexanian
Annals of Internal Medicine|April 1, 1977
Acute leukemia in multiple myelomaF Gonzalez, J M Trujillo, R Alexanian
Hematological Oncology|April 1, 1988
High dose melphalan for refractory myeloma--the M.D. Anderson experienceB Barlogie, K A Dicke, R Alexanian
Lancet (London, England)|February 27, 1993
Increased neurotoxicity with VAD-cyclosporin in multiple myelomaD M Weber, M A Dimopoulos, R Alexanian
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapyR Alexanian, D Weber, S Giralt, et al.
Gematologiia I Transfuziologiia|August 1, 1991
[Plasma cell myeloma. I. A new concept of disease biology]B Barlogi, J Epstein, P Selvaniagam, et al.
Blood|April 1, 1988
Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvementJ Epstein, B Barlogie, J Katzmann, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
Southern Medical Journal|December 1, 1984
Connective tissue disease manifested as multiple myelomaC J Tula, L Berman, R Alexanian
Journal of the Neurological Sciences|August 23, 2024
Dopaminergic progenitors generated by small molecule approach survived, integrated, and promoted functional recovery in (6-OHDA) mouse model of Parkinson's diseaseArshak R Alexanian, Andrey Sorokin, Megan Duersteler
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 1, 1997
[Multiple myeloma and chronic lymphocytic leukemia]J Labardini-Méndez, R Alexanian, B Barlogie
The New England Journal of Medicine|October 19, 1995
Clinical problem-solving: costly errorsD M Weber, D Daliani, R Alexanian
Annals of Internal Medicine|April 1, 1977
Acute leukemia in multiple myelomaF Gonzalez, J M Trujillo, R Alexanian
Hematological Oncology|April 1, 1988
High dose melphalan for refractory myeloma--the M.D. Anderson experienceB Barlogie, K A Dicke, R Alexanian
Lancet (London, England)|February 27, 1993
Increased neurotoxicity with VAD-cyclosporin in multiple myelomaD M Weber, M A Dimopoulos, R Alexanian
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapyR Alexanian, D Weber, S Giralt, et al.
Gematologiia I Transfuziologiia|August 1, 1991
[Plasma cell myeloma. I. A new concept of disease biology]B Barlogi, J Epstein, P Selvaniagam, et al.
Blood|April 1, 1988
Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvementJ Epstein, B Barlogie, J Katzmann, et al.
Pageof 20